Abstract
The effects ofd-Met2, Pro5-enkephalinamide (EA) on pain tolerance and some cognitive functions have been examined in healthy male volunteers. Dihydrocodeine (DC) was used as reference substance. Applying the submaximum effort tourniquet technique EA (10 mg SC) was found to elevate the pain threshold similarly to DC (20 mg SC). Neither DC nor EA impaired the performance in the symbol cancellation test, which quantitates the intensity of attention. In this assay rather a slight improvement was detected. In addition the short-term memory performance (Wechsler test) was also improved by EA and DC. No alteration was seen in the word fluency test, an indicator of long-term (semantic) memory. The data show that EA not only improves pain tolerance but some of its mental effects are similar to those of a classical morphine congener DC.
Similar content being viewed by others
References
Allolio B, Winkelmann W, Hipp FX, Kaulen D, Mies R (1982) Effects of a Met-enkephalin analogue on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion. J Clin Endocrinol Metab 55: 1–7
Andersen HB, Jørgensen BC, Enquist A (1982) Epidural Met-enkephalin (FK 33-824). A dose effect study. Acta Anaesth Scand 26:69–71
Bajusz S, Rónai AZ, Székely JI, Gráf L, Dunai-Kovács Z, Berzétei I (1977) A superactive antinociceptive pentapeptide, (d-Met2, Pro5)-enkephalinamide. FEBS Lett 76: 91–92
Bloomfield SS, Barden TP, Mitchell J (1983) Metkephamid and meperidine analgesia after episiotomy. Clin Pharmacol Ther 34: 240–247
Brownell J, del Pozo E, Donatsch P (1980) Inhibition of vasopressin secretion by Met-enkephalin (FK 33-824) in humans. Acta Endocrinol 84: 304–308
Calimlim JF, Wardell WM, Sriwatanakul K, Lasagna L, Cox C (1982) Analgesic efficacy of parenteral metkephamid acetate in treatment of postoperative pain. Lancet i: 1374–1375
Catlin DH, George R, Li CH (1977a) β-endorphin: pharmacologic and behavioural activity in cats after low intravenous doses. Life Sci 23: 2147–2153
Catlin DH, Hui KK, Loh HH, Li CH (1977b) Pharmacologic activity of β-endorphin in man. Commun Psychopharmacol 1: 439–442
Földes J, Török K, Székely JI, Borvendég J, Karczag I, Tolna J, Marosfi S, Váradi A, Gara Á, Rónai AZ, Szilágyi G (1983) Human tolerability studies withd-Met2, Pro5-enkephalinamide. Life Sci 33: 769–772
Frederickson RCA, Smithwick EL, Shuman R, Bemis KG (1981) Metkephamid, a systemically active analogue of methionine enkephalin with potent opioid δ-receptor activity. Science 211: 603–605
Gaillard RC, Grossman A, Smith R, Rees LH, Besser GM (1981) The effects of a Met-enkephalin analogue on ACTH, β-LPH, β-endorphin and Met-enkephalin in patients with adrenocortical disease. Clin Endocrinol 14: 471–476
Guilford JP (1967) The nature of human intelligence. McGraw-Hill Book Company, New York, pp 138–170
Guillemin H, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F (1977) β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197: 1367–1369
Jørgensen A, Fog H, Veilis B (1979) Synthetic enkephalin analogue in treatment of schizophrenia. Lancet i: 955
Katakami H, Kato Y, Matsushita N, Hiroto S, Shimatsu A, Imura H (1981) Involvement of alpha-adrenergic mechanisms in growth hormone release induced by opioid peptides in conscious rats. Neuroendocrinology 33: 129–135
Krebs E, Roubicek J (1979) EEG and clinical profile of a synthetic analogue of methionine-enkephalin — FK 33-824. Pharmakopsychiatr Neuro-Psychopharmakol 12: 86–93
Le Toulouse D, VAschide N, Piéron H (1904) Technique de psychologie expérimentale Octave Doin, Paris, pp 177–185
Liljequist R (1981) Codeine-induced memory changes: nature and relationship to opiate system. Eur J Clin Pharmacol 20: 99–107
Mondadori C, Waser PG (1978) Improvement of retention by posttrial morphine. Experientia 34: 902
Nedopil N, Rüther E (1979) Effects of the synthetic analogue of methionine enkephalin FK 33-824 on psychotic symptoms. Pharmakopsychiatr Neuro-Psychopharmakol 12: 277–280
Oleson DS, Zubek JP (1970) Effect of one day of sensory deprivation on a battery of open-ended cognitive tests. Perceptual Motor Skills 31: 919–923
Olive H (1972) A note on sex differences in adolescents' divergent thinking. J Psychol 82: 39–42
Oyama T, Jin T, Yamaya R, Ling R, Guillemin R (1980a) Profound analgesic effect of β-endorphin in man. Lancet i: 122–124
Oyama T, Matsuki A, Taneichi T, Ling N, Guillemin R (1980b) β-endorphin in obstetric analgesia. Am J Obstet Gynecol 137: 613–617
Peñalva A, Villanueva L, Casanueva F, Cavagnini F, Gomez-Pan A, Müller EE (1983) Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analogue FK 33-824 in man. Psychopharmacology 80: 120–124
Rapaport SI, Klee WA, Pettigrew KD, Ohno K (1980) Entry of opioid peptides into the central nervous system. Science 207: 84–86
Römer D, Büscher HH, Hill RC, Pless J, Bauer W, Cardinaux F, Closse A, Hauser D, Huguenin R (1977) A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity. Nature 268: 547–549
Scott J, Huskisson EC (1976) Graphic representation of pain. Pain 2: 175–184
Smith GM, Egbert LD, Markowitz RA, Mosteller F, Beecher HK (1966) An experimental pain method sensitive to morphine in man: the submaximum effort tourniquet technique. J Pharmacol Exp Ther 154: 324–332
Stacher G, Bauer P, Steinberger H, Schreiber E, Schmierer G (1979) Effects of the synthetic enkephalin analogue FK 33-824 on pain threshold and pain tolerance in man. Pain 7: 159–172
Stubbs WA, Delitala G, Jones A, Jeffcoate WJ, Edwards CRW, Ratter SJ, Besser GM, Bloom SR, Alberti KGMM (1978) Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet ii: 1225–1227
Székely JI (1982) Effects of opiates on conditioned behaviour. In: Székely JI, Rónai AZ Opioid peptides, vol I, chap 2/VIII, CRC Press, Boca Raton, Florida, pp 73–74
Székely JI, Rónai AZ, Dunai-Kovács Z, Miglécz E, Berzétei I, Bajusz S, Gráf L (1977) (d-Met2, Pro5)-enkephalinamide: a potent morphine-like analgesic. Eur J Pharmacol 43: 293–294
Von Graffenried B, del Pozo E, Roubicek J, Krebs E, Poldinger W, Burmeister P, Kerp L (1978) Effects of the synthetic enkephalin analogue FK 33-824 in man. Nature 272: 729–731
Wechsler D, (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York, pp 43–44
Weingartner H, Kaye W, Gold P, Smallberg S, Peterson R, Gillin JC, Ebert M (1981) Vasopressin treatment of cognitive dysfunction in progressive dementia. Life Sci 29: 2721–2726
White N, Major R, Siegel J (1978) Effects of morphine on one-trial appetitive learning. Life Sci 23: 1967–1972
Woods JH, Herling S, Young AM (1981) Comparison of discriminative and reinforcing stimulus characteristics of morphine-like opioids and two met-enkephalin analogues. Neuropeptides 1: 409–419
Zerbe RL, Henry DP, Robertson GL (1982) A new Met-enkephalin analogue suppresses plasma vasopressin in man. Peptides 1: 199–201
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Székely, J.I., Török, K., Karczag, I. et al. Effects of D-Met2, Pro5-enkephalinamide on pain tolerance and some cognitive functions in man. Psychopharmacology 89, 409–413 (1986). https://doi.org/10.1007/BF02412112
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02412112